LANOPEPDEN MESYLATE
UNII YW25HPP501

Substance Identification & Data

This profile provides standardized clinical and technical data for Lanopepden Mesylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YW25HPP501.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1441390-17-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YW25HPP501

CAS Registry Number

1441390-17-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LANOPEPDEN MESYLATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H34FN7O4.CH4O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UNGNACZMQRGYNV-URBRKQAFSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C170093

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

71571564

Unique identification number in the NCBI database of chemical substances.

USAN ID

BC-71

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CS(O)(=O)=O.C(=O)N(O)C[C@H](C(=O)NNc1nc(nc(c1F)N2C[C@]3(COCCN3CC2)[H])C)CC4CCCC4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lanopepden Mesylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LANOPEPDEN MESYLATE

Common Names & Synonyms

GSK-1322322 MESYLATE

LANOPEPDEN MESILATE

LANOPEPDEN MESILATE [WHO-DD]

LANOPEPDEN MESYLATE [USAN]

Systematic Nomenclature

CYCLOPENTANEPROPANOIC ACID, .ALPHA.-((FORMYLHYDROXYAMINO)METHYL)-, (.ALPHA.R)-, 2-(5-FLUORO-6-((9AS)-HEXAHYDROPYRAZINO(2,1-C)(1,4)OXAZIN-8(1H)-YL)-2-METHYL-4-PYRIMIDINYL)HYDRAZIDE, METHANESULFONATE (1:1)

SYS